Molecular Innovation & AI
Private
15 members
Free
Molecular Innovation and AI-Enabled Drug Discovery
Experimental Pharmacology, Emerging Research Compounds, and Translational Evidence
Start Date: January 1st, 2027
NEW AI Innovations have allowed us to create AI-enabled drug discoveries. We will learn about AI's role and how to use it to simulate this. Also we will go over: Mechanism-driven targets; experimental pharmacology; PK/ADME; assays and models; biomarkers, safety, and translation; and critical evidence appraisal. Research compounds are a limited overview.
Safety
Work is theoretical, computational, or based on public literature. No sourcing, synthesis, preparation, administration, dosing, self-experimentation, or clinical recommendations. Discussion does not imply approval, safety, effectiveness, availability, or endorsement. Status claims require a jurisdiction and as-of date.
powered by
skool.com/pep-talks-wnico-3005
AI-driven drug discovery: mechanisms, experimental pharmacology, translational evidence, responsible AI, and research-compound appraisal.
01/01/2027